Detalles de la búsqueda
1.
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFß signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model.
Cancer Gene Ther
; 31(4): 574-585, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267626
2.
The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFß Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model.
Res Sq
; 2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37790556
Resultados
1 -
2
de 2
1
Próxima >
>>